Recently Viewed
Clear AllQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹993 Cr
Revenue (TTM)
₹544 Cr
Net Profit (TTM)
₹88 Cr
ROE
23.9 %
ROCE
22 %
P/E Ratio
11.3
P/B Ratio
2.5
Industry P/E
26.59
EV/EBITDA
7.6
Div. Yield
0.7 %
Debt to Equity
0.3
Book Value
₹136.9
EPS
₹30.4
Face value
5
Shares outstanding
29,430,987
CFO
₹558.80 Cr
EBITDA
₹624.27 Cr
Net Profit
₹283.60 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Fermenta Biotech
| -3.1 | 3.7 | -3.6 | 18.2 | 46.6 | 5.0 | 19.2 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Fermenta Biotech
| -11.1 | 121.1 | -7.0 | -40.1 | -9.3 | 25.2 | -29.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Fermenta Biotech
|
337.3 | 992.6 | 543.7 | 85.0 | 17.3 | 23.7 | 11.3 | 2.5 |
| 2,791.2 | 34,920.1 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 7,827.5 | 19,544.3 | 2,177.5 | 200.9 | 11.3 | 26.5 | 97.3 | 23.5 | |
| 1,565.8 | 11,917.5 | 2,089.5 | 622.0 | 31.3 | 20.4 | 19.4 | 3.6 | |
| 1,332.1 | 18,429.0 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.7 | 5.1 | |
| 1,961.1 | 31,410.1 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.7 | 7.8 | |
| 4,887.1 | 22,333.8 | 2,482.3 | 853.6 | 33.7 | 18.9 | 26.2 | 5.6 | |
| 4,778.6 | 7,918.9 | 1,348.5 | 293.5 | 28.1 | 50.7 | 27 | 11.4 | |
| 388.9 | 7,603.2 | 1,432.0 | 149.0 | 19.1 | 7.9 | 50.7 | 3.1 | |
| 971.2 | 8,938.5 | 4,725.6 | 528.7 | 14.9 | 20.7 | 17.5 | 3.0 |
No Review & Analysis are available.
DIL Limited, together with its subsidiaries, manufactures and sells bulk drugs and enzymes in India, Europe, and internationally. The company operates through Property and Chemicals segments. It is also involved in renting of properties. The company... was formerly known as Duphar-Interfran Ltd. The company was founded in 1951 and is based in Thane, India. DIL Limited is a subsidiary of DVK Investments Private Limited. Read more
Incorporated
1951
Chairman
--
Managing Director
Prashant Nagre
Headquarters
Thane, Maharashtra
Website
Looking for more details about Fermenta Biotech Ltd.’s IPO? Explore our IPO Details page.
Annual Reports
Announcements
View AnnouncementsThe share price of Fermenta Biotech Ltd is ₹337.25 (BSE) as of 02-Apr-2026 IST. Fermenta Biotech Ltd has given a return of 46.64% in the last 3 years.
The P/E ratio of Fermenta Biotech Ltd is 11.31 times as on 02-Apr-2026, a 57 discount to its peers’ median range of 26.59 times.
The P/B ratio of Fermenta Biotech Ltd is 2.46 times as on 02-Apr-2026, a 45 discount to its peers’ median range of 4.49 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
10.38
|
2.20
|
|
2024
|
0.00
|
1.58
|
|
2023
|
0.00
|
1.02
|
|
2022
|
38.41
|
1.66
|
|
2021
|
15.87
|
2.07
|
The 52-week high and low of Fermenta Biotech Ltd are Rs 399.00 and Rs 241.30 as of 04-Apr-2026.
Fermenta Biotech Ltd has a market capitalisation of ₹ 993 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Fermenta Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.